Form 4 for CSTL CASTLE BIOSCIENCES INC
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-04 · accession 0001447362-23-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-05 | 2023-04-04 | CSTL | Stokes Frank | CFO | M - OptEx | $3.38 | +4,000 | 23.4K | +21% | +$13.5K |
| D | 2023-04-05 | 2023-04-04 | CSTL | Stokes Frank | CFO | M - OptEx | $0.00 | -4,000 | 18.7K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-04 | M | A | 4,000 | $3.38 | 23,419 | D | — | — | (F1) Includes 880 shares acquired on February 28, 2023, under the Issuer's employee stock purchase plan. |
| 2 | Derivative | Stock option (right to buy) | 2023-04-04 | M | D | 4,000 | $0.00 | 18,712 | D | $3.38 · — to 2029-03-12 | 4,000 Common Stock | (F2) The shares subject to the option are fully vested. |